AiM  Vol.6 No.3 , March 2016
Detection of blaNDM-1 and Genetic Relatedness in Clinical Isolates of Escherichia coli Producing Extended Spectrum β-Lactamase from Tertiary Care Centres in South India
Abstract: Background: Extended spectrum β-lactamases (ESBL) producing E. coli co-producing other β-lactamases and exhibiting co-resistance to different antibiotic classes continue to emerge as a threat to clinical field. This study aimed to analyze the co-production of New Delhi metallo-β-lactamase-1 (blaNDM-1) in ESBL producing plasmid-bearing clinical isolates collected from two tertiary care centres in Kerala, South India, and to understand their genetic relatedness. Methods: Antibiotic resistance phenotypes of 44 clinical isolates were determined by disc-diffusion method. Plasmid-bearing isolates, detected by the alkaline-lysis method, which also tested positive for ESBL production, were screened for the presence of blaNDM-1 by polymerase chain reaction. Plasmid, random amplified polymorphic DNA profiles and blaNDM-1 sequence-based phylogenetic tree were analyzed to understand the genotypic similarities among the isolates. Results: Beta-lactam antibiotics, quinolones, cephalosporins, used in this study, and AZM were found to be ineffective against the isolates as significantly high number of isolates were resistant to these antibiotics (P < 0.01). Plasmid bearing isolates constituted 57% (n = 25), all of which were found to be ESBL producers. blaNDM-1 amplicons were noticed in four (16%) isolates and these DNA sequences showed homology between them and with similar sequences reported from other countries like Japan and Korea. Plasmid and RAPD profiles demonstrated that most of the isolates, including those harbouring blaNDM-1 shared genetic similarities as well as an apparent geographical distinctiveness. Conclusion: The predominance of ESBL production and the occurrence of blaNDM-1 in plasmid-bearing isolates observed in our study corroborate the worldwide drug-resistance scenario. This study thus warrants the need for constant surveillance in the face of sparse information available in Kerala State on the emerging drug resistance in clinical bacteria.
Cite this paper: Narayanan, N. , Suresh, M. , Rajamma, J. and Ramakrishnan, M. (2016) Detection of blaNDM-1 and Genetic Relatedness in Clinical Isolates of Escherichia coli Producing Extended Spectrum β-Lactamase from Tertiary Care Centres in South India. Advances in Microbiology, 6, 125-132. doi: 10.4236/aim.2016.63013.

[1]   Alipourfard, I. and Nili, N.Y. (2010) Antibiogram of Extended Spectrum Beta-Lactamase (ESBL) Producing Escherichia coli and Klebsiella pneumoniae Isolated from Hospital Samples. Bangladesh Journal of Medical Microbiology, 4, 32-36.

[2]   Brolund, A. (2014) Overview of ESBL-Producing Enterobacteriaceae from a Nordic Perspective. Infection Ecology and Epidemiology, 4, 24555.

[3]   Chaudhary, U. and Aggarwal, R. (2004) Extended Spectrum β-Lactamases (ESBL)—An Emerging Threat to Clinical Therapeutics. Indian Journal of Medical Microbiology, 22, 75-80.

[4]   Auer, S., Wojna, A. and Hell, M. (2010) Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli. Antimicrobial Agents and Chemotherapy, 54, 4006-4008.

[5]   Dhillon, R.H.-P. and Clark, J. (2012) ESBLs: A Clear and Present Danger? Critical Care Research and Practice, 2012, 11 p.

[6]   Nakamura, T., Komatsu, M., Yamasaki, K., Fukuda, S., Miyamoto, Y., Higuchi, T., Ono, T., Nishio, H., Sueyoshi, N., Kida, K., Satoh, K., Toda, H., Toyokawa, M., Nishi, I., Sakamoto, M., Akagi, M., Nakai, I., Kofuku, T., Orita, T., Wada, Y., Zikimoto, T., Koike, C., Kinoshita, S., Hirai, I., Takahashi, H., Matsuura, N. and Yamamoto, Y. (2012) Epidemiology of Escherichia coli, Klebsiella Species, and Proteus mirabilis Strains Producing Extended-Spectrum β-Lactamases from Clinical Samples in the Kinki Region of Japan. American Journal of Clinical Pathology, 137, 620-626.

[7]   Mohanalakshmi, T., Sandhya Rani, T., Sankeerthi, C.H., Sai Ravi Kiran, B., Sreenivasulu Reddy, V. and Prabhakar Reddy, E. (2014) A Report on Extended-Spectrum β-Lactamases (ESBLs) Producing Escherichia coli Isolated from Clinical Samples. Current Research in Microbiology and Biotechnology, 2, 347-350.

[8]   Rath, S., Dubey, D., Sahu, M.C. and Padhy, R.N. (2014) Surveillance of ESBL Producing Multidrug Resistant Escherichia coli in a Teaching Hospital in India. Asian Pacific Journal of Tropical Disease, 4, 140-149.

[9]   Morosini, M.-I., Garcia-Castillo, M., Coque, T.M., Valverde, A., Novais, A., Loza, E., Baquero, F. and Canton, R. (2006) Antibiotic Coresistance in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae and in Vitro Activity of Tigecycline. Antimicrobial Agents and Chemotherapy, 50, 2695-2699.

[10]   Alagesan, M., Gopalakrishnan, R., Panchatcharam, S.N., Dorairajan, S., Ananth, T.M. and Venkatasubramanian, R. (2015) A Decade of Change in Susceptibility Patterns of Gram-Negative Blood Culture Isolates: A Single Center Study. Germs, 5, 65-77.

[11]   Nordmann, P., Naas, T. and Poirel, L. (2011) Global Spread of Carbapenemase-Producing Enterobacteriaceae. Emerging Infectious Diseases, 17, 1791-1798.

[12]   Zhang, X., Lou, D., Xu, Y., Shang, Y., Li, D., Huang, X., Li, Y., Hu, L., Wang, X. and Yu, F. (2013) First Identification of Coexistence of blaNDM-1 and blaCMY-42 among Escherichia coli ST167 Clinical Isolates. BMC Microbiology, 13, 282.

[13]   Doi, Y., O’Hara, J.A., Lando, J.F., Querry, A.M., Townsend, B.M., Pasculle, A.W. and Muto, C.A. (2014) Co-Production of NDM-1 and OXA-232 by Klebsiella pneumoniae. Emerging Infectious Diseases, 20, 163-165.

[14]   Khajuria, A., Praharaj, A.K., Kumar, M. and Grover, N. (2014) Emergence of Escherichia coli, Co-Producing NDM-1 and OXA-48 Carbapenemases, in Urinary Isolates, at a Tertiary Care Centre at Central India. Journal of Clinical and Diagnostic Research, 8, DC01-DC04.

[15]   Pokhrel, R.H., Thapa, B., Kafle, R., Shah, P.K. and Tribuddharat, C. (2014) Co-Existence of Beta-Lactamases in Clinical Isolates of Escherichia coli from Kathmandu, Nepal. BMC Research Notes, 7, 694.

[16]   Woo, P., Leung, P., Leung, K. and Yuen, K.Y. (2000) Identification by 16S Ribosomal RNA Gene Sequencing of an Enterobacteriaceae Species from a Bone Marrow Transplant Recipient. Molecular Pathology, 53, 211-215.

[17]   Bauer, A.W., Kirby, W.M., Sherris, J.C. and Turck, M. (1966) Antimicrobial Susceptibility Testing by a Standardized Single Disc Method. American Journal of Clinical Pathology, 45, 493-496.

[18]   Clinical and Laboratory Standards Institute (CLSI) (2012) Performance Standards for Antimicrobial Susceptibility Testing. 22nd Informational Supplement: M100-S22.

[19]   Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning—A Laboratory Manual. 2nd Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor.

[20]   Keller, G.H. and Manak, M.M. (1989) Extraction of DNA from Bacterial Cells. DNA Probes, Macmillan Publishers Ltd.

[21]   Poirel, L., Dortet, L., Bernabeu, S. and Nordmann, P. (2011) Genetic Features of blaNDM-1-Positive Enterobacteriaceae. Antimicrobial Agents and Chemotherapy, 55, 5403-5407.

[22]   Poirel, L., Walsh, T.R., Cuvillier, V. and Nordmann, P. (2011) Multiplex PCR for Detection of Acquired Carbapenemase Genes. Diagnostic Microbiology and Infectious Disease, 70, 119-123.

[23]   Altschul, S.F., Madden, T.L., Schaffer, A.A., Zhang, J., Zhang, Z., Miller, W. and Lipman, J. (1997) Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs. Nucleic Acids Research, 25, 3389-3402.

[24]   Edgar, R.C. (2004) MUSCLE: Multiple Sequence Alignment with High Accuracy and High Throughput. Nucleic Acids Research, 32, 1791-1797.

[25]   Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M. and Kumar, S. (2011) MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Molecular Biology and Evolution, 28, 2731-2739.

[26]   Mushtaq, S., Irfan, S., Sarma, J.B., Doumith, M., Pike, R., Pitout, J., Livermore, D.M. and Woodford, N. (2011) Phylogenetic Diversity of Escherichia coli Strains Producing NDM-Type Carbapenemases. Journal of Antimicrobial Chemotherapy, 66, 2002-2005.

[27]   Cai, J.C., Zhang, R., Hu, Y.Y., Zhou, H.W. and Chen, G.-X. (2014) Emergence of Escherichia coli Sequence Type 131 Isolates Producing KPC-2 Carbapenemase in China. Antimicrobial Agents and Chemotherapy, 58, 1146-1152.

[28]   Yong, D., Toleman, M.A., Giske, C.G., Cho, H.S., Sundman, K., Lee, K. and Walsh, T.R. (2009) Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India. Antimicrobial Agents and Chemotherapy, 53, 5046-5054.

[29]   Ahmed, G.U., Bora, A., Hazarika, N.K., Prasad, K.N., Randhawa, V., Sarma, J.B. and Shukla, S.K. (2013) Incidence of blaNDM-1 Gene in Escherichia coli Isolates at a Tertiary Care Referral Hospital in Northeast India. Indian Journal of Medical Microbiology, 31, 250-256.

[30]   Pfeifer, Y., Witte, W., Holfelder, M., Busch, J., Poirel, L. and Nordmann, P. (2011) NDM-1-Producing Escherichia coli in Germany. Antimicrobial Agents and Chemotherapy, 55, 1318-1319.

[31]   Nielsen, J.B., Hansen, F., Littauer, P., Schonning, K. and Hammerum, A.M. (2012) An NDM-1-Producing Escherichia coli Obtained in Denmark Has a Genetic Profile Similar to an NDM-1-Producing E. coli Isolate from the UK. Journal of Antimicrobial Chemotherapy, 67, 2049-2051.

[32]   Liu, Z., Li, W., Wang, J., Pan, J., Sun, S., Yu, Y., Zhao, B., Ma, Y., Zhang, T., Qi, J., Liu, G. and Lu, F. (2013) Identification and Characterization of the First Escherichia coli Strain Carrying NDM-1 Gene in China. PLoS ONE, 8, e66666.